- Home
- OCCI vs ANIX Comparison
OCCI vs ANIX Comparison
Compare OCCI & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCCI
- ANIX
- Stock Information
- Founded
- OCCI N/A
- ANIX 1982
- Country
- OCCI United States
- ANIX United States
- Employees
- OCCI N/A
- ANIX N/A
- Industry
- OCCI Trusts Except Educational Religious and Charitable
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- OCCI Finance
- ANIX Health Care
- Exchange
- OCCI Nasdaq
- ANIX Nasdaq
- Market Cap
- OCCI 117.5M
- ANIX 101.4M
- IPO Year
- OCCI N/A
- ANIX 1987
- Fundamental
- Price
- OCCI $7.11
- ANIX $3.20
- Analyst Decision
- OCCI
- ANIX Strong Buy
- Analyst Count
- OCCI 0
- ANIX 2
- Target Price
- OCCI N/A
- ANIX $8.50
- AVG Volume (30 Days)
- OCCI 115.8K
- ANIX 128.2K
- Earning Date
- OCCI 12-11-2023
- ANIX 01-14-2025
- Dividend Yield
- OCCI 24.32%
- ANIX N/A
- EPS Growth
- OCCI N/A
- ANIX N/A
- EPS
- OCCI N/A
- ANIX N/A
- Revenue
- OCCI N/A
- ANIX N/A
- Revenue This Year
- OCCI N/A
- ANIX N/A
- Revenue Next Year
- OCCI $10.19
- ANIX N/A
- P/E Ratio
- OCCI N/A
- ANIX N/A
- Revenue Growth
- OCCI N/A
- ANIX N/A
- 52 Week Low
- OCCI $5.47
- ANIX $2.15
- 52 Week High
- OCCI $10.15
- ANIX $5.13
- Technical
- Relative Strength Index (RSI)
- OCCI 46.64
- ANIX 48.30
- Support Level
- OCCI $7.02
- ANIX $3.07
- Resistance Level
- OCCI $7.42
- ANIX $3.26
- Average True Range (ATR)
- OCCI 0.12
- ANIX 0.28
- MACD
- OCCI 0.01
- ANIX -0.04
- Stochastic Oscillator
- OCCI 29.55
- ANIX 15.25
About OCCI OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation. The company invests in floating rate credit instruments and other structured credit investments, including; collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.